Drug Profile
Yersinia pestis vaccine - Jiangsu Provincial Center for Disease Control and Prevention
Latest Information Update: 15 Oct 2018
Price :
$50
*
At a glance
- Originator Lanzhou Institute of Biological Products
- Developer Jiangsu Provincial Center for Disease Control and Prevention; Lanzhou Institute of Biological Products
- Class Plague vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Plague
Most Recent Events
- 15 Oct 2018 No recent reports on development identified- phase II for Plague (Prevention) in China (IM)
- 01 Oct 2014 Phase-II clinical trials in Plague (Prevention) in China (Intramuscular)